Adherence to hepatitis A travel health guidelines: A cross-sectional seroprevalence study in Dutch travelling families - The Dutch travel Vaccination Study (DiVeST)

This Dutch travel Vaccination Study (DiVeST) aimed to study adherence or compliance to Dutch travel health guidelines in travelling families and to identify risk groups to provide better advice and protection for international travellers. Between 2016 and 2018, family members who travelled to Easter...

Full description

Saved in:
Bibliographic Details
Published in:Travel medicine and infectious disease 2019-11, Vol.32, p.101511-101511, Article 101511
Main Authors: Doornekamp, Laura, GeurtsvanKessel, Corine, Slobbe, Lennert, te Marvelde, Merel R., Scherbeijn, Sandra M.J., van Genderen, Perry J.J., van Gorp, Eric C.M., Goeijenbier, Marco
Format: Article
Language:English
Subjects:
Antibodies
Childrens health
Compliance
Education
Families & family life
Family medical history
Guideline adherence
Guidelines
Health behavior
Hepatitis
Hepatitis A
Immunisation
Immunization
Infectious diseases
Records
Schools
Secondary schools
Travel
Travel medicine
Vaccination
Vaccination coverage
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Dutch travel Vaccination Study (DiVeST) aimed to study adherence or compliance to Dutch travel health guidelines in travelling families and to identify risk groups to provide better advice and protection for international travellers. Between 2016 and 2018, family members who travelled to Eastern Europe or outside Europe during the preceding year were recruited via Dutch secondary schools. The vaccination status of the travellers was assessed using questionnaires and vaccination records and hepatitis A virus antibody concentrations in dried blood spot (DBS) eluates. Subgroups of travellers with lower adherence to guidelines were identified. Of the 246 travellers that participated in this study, 155 (63%) travelled to destinations for which the HAV vaccination was recommended. Of these 155 travellers, 56 (36%) said they visited a pre-travel clinic, and 64 of them (41%) showed a valid HAV vaccination in their vaccination records. Of the 145 travellers with available DBS eluates, anti-HAV antibodies were detected in 98 (68%) of them. We found that adherence to travel health guidelines, in terms of HAV vaccination, was suboptimal. According to our results, specific attention should be paid to children, persons visiting friends and relatives and those who travel relatively short distances.
ISSN:1477-8939
1873-0442
DOI:10.1016/j.tmaid.2019.101511